India approves pandemic vaccine
The pharmaceutical company Zydus Cadila announced today it has gained approval from the drug controller general of India to become the first India-based firm to market a pandemic H1N1 vaccine in the country. The vaccine, VaxiFlu-S, will be marketed by Vaxxicare, part of a division of the company that focuses on preventives.